Secondary Logo

Journal Logo

AAPA Members can view Full text articles for FREE. Not a Member? Join today!

Institutional members access full text with Ovid®

What do PAs need to know about prescription drug monitoring programs?

Mospan, Geoffrey A. PharmD, BCPS; Lucas, Austin

Journal of the American Academy of PAs: July 2017 - Volume 30 - Issue 7 - p 11–12
doi: 10.1097/01.JAA.0000520545.53946.82
Pharmacology Consult
Buy

ABSTRACT As controlled-substance abuse continues to increase in the United States, clinicians find themselves on the front lines of this epidemic. State-operated prescription drug monitoring programs are a valuable resource that prescribers can use to see patients' controlled substance history. Despite some limitations, these programs have been shown to be an effective method in reducing overdose deaths and the supply of controlled substances in the community.

Geoffrey A. Mospan is an assistant professor of pharmacy, pharmacy law, and internal medicine at Wingate University School of Pharmacy in Wingate, N.C. Austin Lucas is a doctor of pharmacy candidate at Wingate University School of Pharmacy. The authors have disclosed no potential conflicts of interest, financial or otherwise.

Mary Lou Brubaker, PharmD, PA-C, department editor

Copyright © 2017 American Academy of Physician Assistants
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website